Cushing's Syndrome & Hypokalaemia
How glucocorticoid excess causes increased urinary potassium excretion
Short Answer: Yes. In Cushing's syndrome, extremely high cortisol levels overwhelm the kidney's protective enzyme (11β-HSD2), allowing cortisol to activate mineralocorticoid receptors. This mimics aldosterone, causing the kidneys to waste potassium in the urine.
1. Normal Protection: The enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) in the kidney converts active cortisol → inactive cortisone. This prevents cortisol from binding to mineralocorticoid receptors (MR), which should only respond to aldosterone.
2. In Cushing's Syndrome: Cortisol levels become so high that they saturate the 11β-HSD2 enzyme.
3. The Spillover: Excess cortisol "spills over" and binds to MR in the distal tubule and collecting duct.
4. Aldosterone-Like Effect: Activated MR increases:
- ENaC channels: ↑ Sodium reabsorption
- Na⁺/K⁺-ATPase: Creates negative luminal charge
- ROMK channels: ↑ Potassium secretion into urine
Result: Sodium retention + Hypertension + Hypokalaemia
Additional Contributing Factors
| Factor | Mechanism | Contribution to Hypokalaemia |
|---|---|---|
| High ACTH (Ectopic Cushing's) |
Stimulates adrenal production of other mineralocorticoids (e.g., deoxycorticosterone/DOC) | Adds direct mineralocorticoid effect |
| Glucocorticoid-Induced Hypertension | Volume expansion suppresses endogenous aldosterone, but cortisol continues to activate MR | Hypokalaemia persists despite low aldosterone |
| Apparent Mineralocorticoid Excess (AME) | Genetic deficiency of 11β-HSD2 (mimics Cushing's physiology) | Confirms the cortisol-MR pathway as causative |
Pathway Summary
│
▼
Very High Serum Cortisol
│
▼
11β-HSD2 Enzyme Saturated
│
▼
Cortisol Binds Mineralocorticoid Receptors (Kidney)
│
▼
↑ ENaC + ↑ Na⁺/K⁺-ATPase + ↑ ROMK Channels
│
▼
↑ Sodium Reabsorption + ↑ Potassium Secretion
│
▼
Hypertension + HYPOKALAEMIA
🔍 Key Clinical Clues
- Hypokalaemia + Hypertension: Suggests mineralocorticoid excess (Cushing's, primary hyperaldosteronism, or AME).
- Low Plasma Renin Activity (PRA): Seen in both primary hyperaldosteronism and glucocorticoid-mediated MR activation.
- Differentiating Test: Measure serum cortisol and ACTH. In Cushing's, cortisol is high; in primary hyperaldosteronism, it is normal.
- Urine Potassium: High (>20-30 mEq/L) despite low serum potassium confirms renal wasting.
- The 11β-HSD2 enzyme is highly efficient at physiological cortisol concentrations.
- Hypokalaemia typically appears only when cortisol is markedly elevated, the enzyme is genetically deficient (AME), or the enzyme is inhibited (e.g., by glycyrrhizic acid in licorice).
⚕️ Clinical Implication
- Treatment: Address the underlying cause (surgery for adrenal/pituitary tumor, medication adjustment).
- Potassium Replacement: Often required temporarily, but correcting the cortisol excess is definitive.
- Mineralocorticoid Receptor Antagonists: Spironolactone or eplerenone can block the renal effects if surgery is delayed or not possible.
Disclaimer: I am an AI, not a doctor. This information is for educational purposes only and explains physiological mechanisms. It should not be taken as specific medical advice. Hypokalaemia and Cushing's syndrome require professional medical evaluation and management.
Comments